Company Name
WEST BENGAL CHEMICAL INDUSTRIES LIMITED
Year of Establishment
1962
Annual Turnover(USD)
500,000 to 99,999,999
Company Introduction
West Bengal Chemical Industries Limited (WBCIL) is a globally recognized name in the field of Active Pharmaceutical Ingredients (APIs), fine chemicals, and nutraceuticals. With a heritage of over 60 years, WBCIL has earned a reputation for chemical innovation, quality, and manufacturing excellence. Our integrated production facilities in Kolkata (West Bengal) and Dahej (Gujarat) are state-of-the-art and certified by WHO-GMP, ISO, HACCP, and GLP, reflecting our unwavering commitment to international quality and regulatory compliance.
At CPhI China 2025, WBCIL is proud to present its advanced pharmaceutical and nutraceutical portfolio, emphasizing innovation-driven solutions with a focus on Liposomal and Chelated Mineral APIs.
Key Product Segments:
Liposomal Minerals & Vitamins:
Our next-generation liposomal technologies improve bioavailability, absorption, and stability of nutrients. We offer a wide range of liposomal ingredients including Iron, Calcium, Magnesium, Zinc, Vitamin C, D3, K2, B1, B6, and B12, ideal for supplements, functional foods, and therapeutic formulations.
Injectable Iron APIs:
WBCIL manufactures high-purity injectable iron formulations such as Iron Isomaltoside, Iron Polymaltose, and Ferric Carboxymaltose, known for high absorption efficiency and minimal gastrointestinal discomfort, particularly effective for treating iron deficiency anemia.
Mineral Chelates:
Our chelated minerals—Ferrous Bisglycinate, Magnesium Bisglycinate, and Calcium Pidolate—offer enhanced bioavailability and tolerance, supporting bone health, metabolic functions, and immune wellness.
Liposomal Dietary Supplements:
Featuring science-backed actives like Liposomal Alpha Lipoic Acid, Curcumin, and Glutathione, our formulations target oxidative stress, inflammation, and detoxification.
Liposomal Cosmeceuticals:
Our dermal-grade ingredients such as Liposomal Ascorbic Acid, Hyaluronic Acid, and Niacinamide cater to skincare, anti-aging, and hydration-focused formulations.
In addition to its manufacturing capabilities, WBCIL is actively seeking dependable partners for the procurement of key raw materials, including citric acid, butyric acid, glycine, and pyroglutamic acid, vital to our expanding nutraceutical lines.
Operating in over 30 countries, WBCIL invites distributors, formulation partners, and raw material suppliers to explore collaborative opportunities. Together, we can create next-generation solutions in healthcare and wellness.
Join us at Booth E1D40, CPhI China 2025, at the Shanghai New International Expo Centre (SNIEC) from June 24–26, and experience the future of liposomal and mineral API innovation.
Main Competitive Advantages
Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Reputation,Quality Service,
Patents and Copyright
❃Ferric Carboxymaltose – Patent No. 370845 & 434424;
❃Iron-Isomaltoside – Patent No. 381772;
❃Iron (III) Coordination Complex – Patent No. 412127;
❃Ferric Derisomaltose – Patent No. 388898;
❃Ferric Citrate – Patent No. 356552;
❃Sucroferric Oxyhydroxide – Patent No. 419785;
❃Enclomiphene Citrate – Patent No. 389779;
❃Ferric Maltol – Patent No. 538762;
❃Ferric Carboxymaltose- Patent No. 566196;
❃Iron Polymaltose Complex - Patent No. 567102.
Milestone
Milestones of West Bengal Chemical Industries Limited (WBCIL)
Established in 1962 in Kolkata, West Bengal Chemical Industries Limited (WBCIL) has been a cornerstone in the pharmaceutical and nutraceutical sectors for over six decades. With a commitment to quality and innovation, WBCIL has consistently expanded its horizons, both in product offerings and global reach.
1962 – Foundation and Early Growth
WBCIL commenced its journey focusing on the manufacturing of Active Pharmaceutical Ingredients (APIs) and fine chemicals. This foundational phase set the stage for future expansions into mineral-based formulations.
Diversification of Product Portfolio
Recognizing the evolving needs of the healthcare industry, WBCIL diversified its product range to include a variety of mineral salts such as Iron, Calcium, Magnesium, Potassium, and Zinc. These products cater to sectors including pharmaceuticals, nutraceuticals, food, and animal nutrition.
New Horizon in Liposomal Technology
WBCIL is at the forefront of innovation with its advanced liposomal technology, enhancing the bioavailability and stability of essential minerals and nutrients. This cutting-edge delivery system ensures better absorption, reduced side effects, and improved patient outcomes across therapeutic segments.
Research and Development Excellence
WBCIL's robust R&D initiatives have led to the development of advanced formulations like liposomal minerals and injectable iron complexes, enhancing bioavailability and patient compliance.
Global Expansion
With a presence in over 30 countries and serving more than 4,000 clients worldwide, WBCIL has established itself as a trusted global supplier of high-quality APIs and nutraceuticals.
Accreditations and Certifications
WBCIL's dedication to excellence is reflected in its numerous certifications, including WHO GMP, ISO, FSSAI, HACCP and FAMI QS, ensuring adherence to international quality and safety standards.
Intellectual Property Achievements
Demonstrating its innovative prowess, WBCIL has secured eleven patents for novel formulations:
Ferric Carboxymaltose – Patent Nos. 370845 & 434424
Iron-Isomaltoside – Patent No. 381772
Iron (III) Coordination Complex – Patent No. 412127
Ferric Derisomaltose – Patent No. 388898
Ferric Citrate – Patent No. 356552
Sucroferric Oxyhydroxide – Patent No. 419785
Enclomiphene Citrate – Patent No. 389779
Ferric Maltol – Patent No. 538762
Ferric Carboxymaltose- Patent No. 566196
Iron Polymaltose Complex - Patent No. 567102
Recognition and Awards
In 2024, WBCIL was honored with the National Intellectual Property Award by the Ministry of Commerce & Industry, Government of India, recognizing its outstanding contributions to patent filing, grant, and commercialization.
Infrastructure Development
To meet growing global demands, WBCIL established a state-of-the-art manufacturing facility in Dahej, Gujarat, complementing its existing operations in Kolkata, and enhancing its production capabilities.
Continued Commitment to Innovation
As WBCIL continues to evolve, its unwavering focus on research, quality, and customer satisfaction positions it as a leader in the pharmaceutical and nutraceutical industries, dedicated to improving health outcomes worldwide.